Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy

American Heart Journal

Volumn 160, Issue 4, 2010, Pages 737-743

  Auger, Dominique ^a   Van Bommel, Rutger J ^a   Bertini, Matteo ^a   Delgado, Victoria ^a   Ng, Arnold C T ^a   Ewe, See Hooi ^a   Shanks, Miriam ^a   Marsan, Nina Ajmone ^a   Mooyaart, Eline A Q ^a   Witkowski, Tomasz ^a   Poldermans, Don ^b   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR REVERSE REMODELING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS COMPLEX; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING; CARDIOVERSION; COMPARATIVE STUDY; CONVALESCENCE; DISEASE COURSE; ECHOGRAPHY; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; TIME;

AGED; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MYOCARDIAL CONTRACTION; PROGNOSIS; RECOVERY OF FUNCTION; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77958077017     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.016     Document Type: Article

References (34)

1. Auricchio A., Stellbrink C., and Sack S. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033 (Pubitemid 34628286)
2. Cleland J.G., Daubert J.C., and Erdmann E. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
3. Bristow M.R., Saxon L.A., and Boehmer J. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
4. Abraham W.T., Fisher W.G., and Smith A.L. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
5. Yu C.M., Bleeker G.B., and Fung J.W. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy Circulation 112 2005 1580 1586
6. Ypenburg C., van Bommel R.J., and Borleffs C.J. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up J Am Coll Cardiol 53 2009 483 490
7. Auricchio A., Kloss M., and Trautmann S.I. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay Am J Cardiol 89 2002 198 203 (Pubitemid 34132910)
8. Cleland J., Freemantle N., and Ghio S. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial J Am Coll Cardiol 52 2008 438 445
9. Cleland J.G., Daubert J.C., and Erdmann E. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
10. Fantoni C., Regoli F., and Ghanem A. Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy Eur J Heart Fail 10 2008 298 307
11. Fornwalt B.K., Sprague W.W., and BeDell P. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy Circulation 121 2010 1985 1991
12. Bleeker G.B., Bax J.J., and Fung J.W. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy Am J Cardiol 97 2006 260 263
13. Chung E.S., Leon A.R., and Tavazzi L. Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2008 2608 2616
14. van Bommel R.J., Bax J.J., and Abraham W.T. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis Eur Heart J 30 2009 2470 2477
15. Vardas P.E., Auricchio A., and Blanc J.J. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the european society of cardiology. Developed in collaboration with the European Heart Rhythm Association Eur Heart J 28 2007 2256 2295
16. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107
17. Lipkin G., Knecht M.E., and Rosenberg M. A potent inhibitor of normal and transformed cell growth derived from contact-inhibited cells Cancer Res 38 1978 635 643
18. Pires L.A., Abraham W.T., and Young J.B. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials Am Heart J 151 2006 837 843
19. Lang R.M., Bierig M., and Devereux R.B. Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
20. Bonow R.O., Carabello B.A., and Chatterjee K. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 2006 e1 e148
21. Yu C.M., Fung W.H., and Lin H. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy Am J Cardiol 91 2003 684 688
22. Delgado V., Ypenburg C., and van Bommel R.J. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy J Am Coll Cardiol 51 2008 1944 1952
23. Alonso C., Leclercq C., and Victor F. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure Am J Cardiol 84 1999 1417 1421
24. Epstein A.E., DiMarco J.P., and Ellenbogen K.A. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
25. Dickstein K., Cohen-Solal A., and Filippatos G. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
26. Bax J.J., Abraham T., and Barold S.S. Cardiac resynchronization therapy: Part 1-issues before device implantation J Am Coll Cardiol 46 2005 2153 2167
27. Anand I.S., Florea V.G., and Fisher L. Surrogate end points in heart failure J Am Coll Cardiol 39 2002 1414 1421
28. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 2000 569 582
29. Foley P.W., Leyva F., and Frenneaux M.P. What is treatment success in cardiac resynchronization therapy? Europace 11 Suppl 5 2009 v58 v65
30. Olsson L.G., Swedberg K., and Clark A.L. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review Eur Heart J 26 2005 778 793
31. Bax J.J., and Gorcsan J. III Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective J Am Coll Cardiol 53 2009 1933 1943
32. Bleeker G.B., Kaandorp T.A., and Lamb H.J. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy Circulation 113 2006 969 976
33. Egoavil C.A., Ho R.T., and Greenspon A.J. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials Heart Rhythm 2 2005 611 615
34. Bleeker G.B., Mollema S.A., and Holman E.R. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline Circulation 116 2007 1440 1448